266 related articles for article (PubMed ID: 29795629)
21. Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis.
Hu T; Li YH; Han WQ; Maduray K; Chen TS; Hao L; Zhong JQ
Am J Cardiovasc Drugs; 2023 Nov; 23(6):683-694. PubMed ID: 37639201
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature.
Dentali F; Botto GL; Gianni M; Ambrosino P; Di Minno MN
Int J Cardiol; 2015 Apr; 185():72-7. PubMed ID: 25791094
[TBL] [Abstract][Full Text] [Related]
23. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.
van Es N; Coppens M; Schulman S; Middeldorp S; Büller HR
Blood; 2014 Sep; 124(12):1968-75. PubMed ID: 24963045
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
[TBL] [Abstract][Full Text] [Related]
25. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
Kirkilesis GI; Kakkos SK; Tsolakis IA
Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
[TBL] [Abstract][Full Text] [Related]
26. The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis.
Li D; Chang P; Zhang H; Bai F; Wu Q
Eur J Clin Pharmacol; 2023 Apr; 79(4):461-471. PubMed ID: 36795127
[TBL] [Abstract][Full Text] [Related]
27. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis.
van der Hulle T; Kooiman J; den Exter PL; Dekkers OM; Klok FA; Huisman MV
J Thromb Haemost; 2014; 12(3):320-8. PubMed ID: 24330006
[TBL] [Abstract][Full Text] [Related]
29. Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis.
Boonyawat K; Caron F; Li A; Chai-Adisaksopha C; Lim W; Iorio A; Lopes RD; Garcia D; Crowther MA
J Thromb Haemost; 2017 Jul; 15(7):1322-1333. PubMed ID: 28407368
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis.
Cavallari I; Verolino G; Romano S; Patti G
Thromb Haemost; 2020 Feb; 120(2):314-321. PubMed ID: 31785599
[TBL] [Abstract][Full Text] [Related]
31. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
López-López JA; Sterne JAC; Thom HHZ; Higgins JPT; Hingorani AD; Okoli GN; Davies PA; Bodalia PN; Bryden PA; Welton NJ; Hollingworth W; Caldwell DM; Savović J; Dias S; Salisbury C; Eaton D; Stephens-Boal A; Sofat R
BMJ; 2017 Nov; 359():j5058. PubMed ID: 29183961
[No Abstract] [Full Text] [Related]
32. Efficacy and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonist (VKA) among patients with atrial fibrillation and hypertrophic cardiomyopathy: a systematic review and meta-analysis.
Rujirachun P; Charoenngam N; Wattanachayakul P; Winijkul A; Owattanapanich W; Ungprasert P
Acta Cardiol; 2020 Dec; 75(8):724-731. PubMed ID: 31558097
[No Abstract] [Full Text] [Related]
33. Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation.
Romero J; Cerrud-Rodriguez RC; Alviz I; Diaz JC; Rodriguez D; Arshad S; Cerna L; Taveras J; Grupposo V; Natale A; Garcia M; Di Biase L
JACC Clin Electrophysiol; 2019 Dec; 5(12):1396-1405. PubMed ID: 31857038
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE.
Bounameaux H; Haas S; Farjat AE; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Schellong S; Mantovani LG; Prandoni P; Kakkar AK
Thromb Res; 2020 Jul; 191():103-112. PubMed ID: 32422442
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis.
Chen HY; Ou SH; Huang CW; Lee PT; Chou KJ; Lin PC; Su YC
Clin Drug Investig; 2021 Apr; 41(4):341-351. PubMed ID: 33709339
[TBL] [Abstract][Full Text] [Related]
36. DOACs Versus VKAs in Older Adults Treated for Acute Venous Thromboembolism: Systematic Review and Meta-Analysis.
Chaudhary R; Pagali S; Garg J; Murad MH; Wysokinski WE; McBane RD
J Am Geriatr Soc; 2020 Sep; 68(9):2021-2026. PubMed ID: 32441334
[TBL] [Abstract][Full Text] [Related]
37. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis.
Dong S; Zhang Y; Li Y; Li Y; Miao Y; Zhao R; Zhai S
Ann Pharmacother; 2021 Apr; 55(4):430-439. PubMed ID: 32938202
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of direct acting oral anticoagulants and vitamin K antagonists in nonvalvular atrial fibrillation - a network meta-analysis of real-world data.
Hirschl M; Kundi M
Vasa; 2019 Mar; 48(2):134-147. PubMed ID: 30376416
[TBL] [Abstract][Full Text] [Related]
39. Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: A systemic review and meta-analysis.
Yamashita Y; Morimoto T; Toyota T; Shiomi H; Makiyama T; Ono K; Kimura T
Thromb Res; 2018 Jun; 166():37-42. PubMed ID: 29655001
[TBL] [Abstract][Full Text] [Related]
40. Safety and effectiveness of direct oral anticoagulants versus vitamin K antagonists: results from 3 Italian regions.
Kirchmayer U; Narduzzi S; Mayer F; Tuccori M; Leoni O; Belleudi V; Di Martino M; Lallo A; Addis A; Davoli M
Recenti Prog Med; 2019 Apr; 110(4):195-202. PubMed ID: 31066365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
